A quantitative framework and strategies for management and evaluation of metabolic drug-drug interactions in oncology drug development: new molecular entities as object drugs.
Venkatakrishnan
Karthik
K
Department of Clinical Pharmacology, Millennium Pharmaceuticals Inc., Cambridge, Massachusetts 02139, USA. karthik.venkatakrishnan@mpi.com
Pickard
Michael D
MD
von Moltke
Lisa L
LL